Andre Rietman

Dr. Andre Rietman serves as a Researcher in the Department of Child and Adolescent Psychiatry / Psychology at Erasmus University Medical Center (Erasmus MC), Rotterdam. His clinical and research activities focus on neurodevelopmental disorders and quality-of-life outcomes for pediatric patients with congenital conditions.

Research interests span developmental disorders including Neurofibromatosis Type 1, Angelman Syndrome, and Fragile X Syndrome, with particular emphasis on psychiatric comorbidities, cognitive functioning, and long-term quality-of-life outcomes. His fingerprint analysis shows strong connections to pervasive developmental disorders (53%), health status assessment (41%), and congenital anomalies like esophageal atresia (67%).

Recent publication trends indicate active involvement in clinical trials (including a Lamotrigine Phase II study for NF1 cognitive deficits) and systematic reviews of psychiatric symptoms in genetic disorders. His work frequently employs cohort studies and meta-analytic approaches to examine internalizing/externalizing behaviors across neurodevelopmental conditions.

Dr. Rietman has supervised at least one doctoral thesis as indicated by "Supervised Work (1)" in his profile. His research collaborations span multiple European institutions with particular activity in neurocognitive assessment tool validation and congenital anomaly outcome studies.